Allon Therapeutics, Inc. reported earnings results for the year ended December 31, 2012. For the year, the company reported a net loss of $14,916,297 or $0.12 per share compared to a net loss of $12,774,995 or $0.15 per share for the year ended December 31, 2011, representing an increase in net loss of $2,141,302.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0001 USD | +9,900.00% | -.--% | +9,900.00% |
1st Jan change | Capi. | |
---|---|---|
+9,900.00% | 14.11K | |
+26.37% | 44.96B | |
-1.01% | 42.65B | |
+46.00% | 41.85B | |
-5.31% | 29.04B | |
+9.34% | 26.08B | |
-21.69% | 19.03B | |
+6.23% | 12.75B | |
+26.99% | 12.06B | |
-3.38% | 11.75B |
- Stock Market
- Equities
- NPCUF Stock
- News Allon Therapeutics Inc.
- Allon Therapeutics, Inc. Reports Earnings Results for the Year Ended December 31, 2012